Favipiravir for the treatment of COVID-19 in elderly patients—what do we know after 2 years of COVID-19?

Since the appearance of coronavirus disease 2019 (COVID-19), numerous studies have been conducted to find effective therapeutics. Favipiravir (FVP) is one of the repurposed drugs which has been authorized in a few countries on an emergency basis to treat COVID-19. Elderly individuals especially 65 y...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	GeroScience 2022-06, Vol.44 (3), p.1263-1268
Hauptverfasser:	Papp, Henrietta, Lanszki, Zsófia, Keserű, György M., Jakab, Ferenc
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Biomedical and Life Sciences Cell Biology Coronaviruses COVID-19 Geriatrics/Gerontology Life Sciences Molecular Medicine Patients Severe acute respiratory syndrome coronavirus 2 Short Communication
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!